DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES Share Price

Certificat

DE000MB96693

Real-time Bid/Ask 17:37:36 30/05/2024 BST
0.018 EUR / 0.04 EUR +52.63% Intraday chart for DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES
1 month-17.39%
3 months-60.42%
Date Price Change
30/05/24 0.018 -5.26%
29/05/24 0.019 +35.71%
28/05/24 0.014 0.00%
27/05/24 0.014 -26.32%
24/05/24 0.019 -5.00%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 02:57 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB9669
ISINDE000MB96693
Date issued 26/07/2023
Strike 140 $
Maturity 21/06/2024 (22 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.089
Lowest since issue 0.011
Spread 0.022
Spread %55.00%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
100.7 USD
Average target price
125.4 USD
Spread / Average Target
+24.46%
Consensus